Q4 2018 Holdings
Filed 2019-02-11 | 14 holdings | $134.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Replimune(REPL) | Common Stock | 76029N106 | $51.0K | 5,103,455 | 37.8% |
| Translate Bio | Common Stock | 89374L104 | $18.3K | 2,437,603 | 13.6% |
| KezarLife Sciences | Common Stock | 49372L100 | $15.9K | 675,623 | 11.8% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $13.3K | 2,600,410 | 9.9% |
| ObsEva | Common Stock | H5861P103 | $12.7K | 999,364 | 9.4% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $6.0K | 130,646 | 4.5% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $4.3K | 551,477 | 3.2% |
| Cidara Therapeutics | Common Stock | 171757107 | $3.5K | 1,508,794 | 2.6% |
| Bssa Pharma(EPIEUR) | Common Stock | 29668H708 | $2.3K | 1,084,848 | 1.7% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $2.1K | 778,230 | 1.5% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $1.8K | 167,157 | 1.3% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $1.8K | 529,965 | 1.3% |
| Sienna Biopharmaceuticals(SNNAQ) | Common Stock | 82622H108 | $1.8K | 758,610 | 1.3% |
| Egalet | Common Stock | 28226B104 | $7 | 2,889,926 | 0.0% |